| Literature DB >> 20226025 |
Chang-Hoon Lee1, Ji-Young Hwang, Dae-Kyu Oh, Mee-Kyung Kee, Eunjung Oh, Jung-Wook An, Jinhyun Kim, Heonsook Do, Hee-Jin Kim, Sung Soon Kim, Hwahyun Kim, Jeong-Gu Nam.
Abstract
BACKGROUND: Although, in South Korea, human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS) keeps increasing and tuberculosis(TB) burden is still significant, there have been few reports on TB/HIV cases. In this study, we investigated the burden and characteristics of TB/HIV patients in South Korea, an area with intermediate burden of TB and a low prevalent area with HIV/AIDS.Entities:
Mesh:
Year: 2010 PMID: 20226025 PMCID: PMC2850338 DOI: 10.1186/1471-2334-10-66
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Figure 1The trends of newly detected HIV infection cases and TB/HIV cases in South Korea (2001-2005).
Characteristics of patients with HIV, patients with TB, and patients with coinfection of TB and HIV in Korea (2001-2005).
| HIV (N = 2,548) | TB (N = 197,562) | HIV & TB (N = 137) | ||||
|---|---|---|---|---|---|---|
| Sex, male : female | 2,355(92.4%):193(7.6%) | 124,183(62.9%):73,379(37.1%) | 132(96.4%):5(3.6%) | |||
| Age, median (range) | 37.0 (4-80) | 44 (0-97) | 39.5 (19.9-79.1) | |||
| 0-9 | 2 (0.1%) | 1,000 (0.5%) | 0 (0%) | |||
| 10-19 | 60 (2.4%) | 12,575 (6.4%) | 1 (0.7%) | |||
| 20-29 | 576 (22.6%) | 39.638 (20.1%) | 19 (13.9%) | |||
| 30-39 | 873 (34.3%) | 32,231 (16.3%) | 51 (37.2%) | |||
| 40-49 | 583 (22.9%) | 30,515 (15.4%) | 41 (29.9%) | |||
| 50-59 | 318 (12.5%) | 23,206 (11.7%) | 14 (10.2%) | |||
| 60- | 136 (5.3%) | 58,397 (29.6%) | 11 (8.0%) | |||
| Year | Cases | Incidence (cases/105) | Cases | Incidence (cases/105) | Cases | Incidence (cases/105) |
| 2001 | 327 | 0.69 | 42,737 | 90.3 | 17 | 0.036 |
| 2002 | 398 | 0.84 | 38,801 | 81.4 | 20 | 0.042 |
| 2003 | 534 | 1.11 | 36,227 | 75.6 | 21 | 0.044 |
| 2004 | 610 | 1.27 | 36,041 | 74.8 | 40 | 0.083 |
| 2005 | 680 | 1.41 | 43,781 | 90.7 | 39 | 0.081 |
| CD4 count at diagnosis, median(IQR) (/mm3) | 315.0 (186.0-464.0) | 301.0 (171.5-460.0) | ||||
| TB type (% among patients with TB) | ||||||
| Pulmonary | 183,640 (92.0%) | 111 (81.0%) | ||||
| Smear positive | 72,599 (36.4%) | 42 (30.7%) | ||||
| Extrapulmonary | 16,021 (8.0%) | 26 (19.0%) | ||||
| Pleurisy | 6,852 (3.4%) | 3 (2.2%) | ||||
| Lymphnode | 3,675 (1.8%) | 10 (7.3%) | ||||
| Gastrointestinal | 1,797 (0.9%) | 5 (3.6%) | ||||
| Nervous | 657 (0.3%) | 3 (2.2%) | ||||
| Skin | 272 (0.1%) | 1 (0.7%) | ||||
| Other organs | 2,169 (1.1%) | 1 (0.7%) | ||||
| Disseminated | 599 (0.3%) | 3 (2.2%) | ||||
SPR of HIV among overall cases with TB.
| Subgroup | No. of TB cases | No. of HIV cases | PR | 95% CI | ||
|---|---|---|---|---|---|---|
| Observed* | Expected | Lower | Upper | |||
| By sex | ||||||
| Male | 124,183 | 132 | 8.21 | 16.09 | 13.46 | 19.08 |
| Female | 73,379 | 5 | 0.65 | 7.87 | 2.54 | 18.37 |
| By age | ||||||
| 0-9 | 1,000 | 0 | 0.00 | 0.00 | NA | 7,800.11 |
| 10-19 | 12,575 | 1 | 0.03 | 34.87 | NA | 193.99 |
| 20-29 | 39,638 | 19 | 1.48 | 12.84 | 7.73 | 20.05 |
| 30-39 | 32,231 | 51 | 2.44 | 20.92 | 15.57 | 27.50 |
| 40-49 | 30,515 | 41 | 1.98 | 20.75 | 14.89 | 28.16 |
| 50-59 | 23,206 | 14 | 1.11 | 12.58 | 6.87 | 21.12 |
| 60- | 58,397 | 11 | 1.02 | 10.79 | 5.38 | 19.30 |
| Male aged 20-59 | 80,599 | 120 | 3.03 | 39.64 | 32.87 | 47.40 |
| Male aged < 19 or ≥ 60 | 43,584 | 12 | 1.64 | 7.33 | 3.78 | 12.81 |
| Pulmonary TB | 183,640 | 111 | 6.90 | 16.09 | 13.24 | 19.38 |
| Smear-positive TB | 72,599 | 42 | 2.73 | 15.40 | 11.10 | 20.82 |
| Extrapulmonary TB | 16,021 | 26 | 0.60 | 43.21 | 28.22 | 63.31 |
| Overall | 197,562 | 85 | 7.42 | 18.46 | 15.50 | 21.83 |